Dalhoff K, Poulsen H E
Department of Medicine A, Rigshospitalet, Copenhagen, Denmark.
Biochem Pharmacol. 1993 Aug 3;46(3):383-8. doi: 10.1016/0006-2952(93)90513-v.
The aim of the present study was to examine the effects of the hepatotoxic drug acetaminophen (AA) on the synthesis rates of glutathione (GSH), activated sulphate (PAPS; adenosine 3'-phosphate 5'-phosphosulphate) and the AA metabolites AA-GSH and AA-sulphate after selective inhibition of GSH biosynthesis or sulphation in isolated rat hepatocytes. Selective inhibition of the two interdependent metabolic pathways was accomplished by buthionine sulphoximine (BSO) and 2,6-dichloro-4-nitrophenol (DCNP). The synthesis rates of GSH and PAPS were determined simultaneously by a previously described method based on trapping of radioactivity (35S) in the pre-labelled GSH and PAPS pools. Pre-incubation with 10 mM BSO for 30 min depleted GSH by 38% (P < 0.05) and PAPS by 27% (P < 0.05). The depletion resulted in increased PAPS synthesis at low, non-toxic [5-19 nmol/(10(6) cells.min)] (P < 0.05) and at high, toxic [7-30 nmol/10(6) cells.min)] (P < 0.05) AA concentrations. In both cases sulphur is diverted from GSH biosynthesis to sulphoxidation and PAPS synthesis, thereby maintaining the PAPS pool and preserving the sulphation capacity. This corresponds to the finding that AA sulphation was unaffected by BSO irrespective of AA concentration [6 vs 5 and 20 vs 17 nmol/(10(6) cells.hr), respectively]. Even though the GSH synthesis was halved after BSO pre-incubation, the GSH conjugating capacity of AA was well preserved. Incubation with 200 microM DCNP and 5 mM AA diminished PAPS synthesis from 24 to 10 nmol/(10(6) cells.min) (P < 0.02) and reduced AA-sulphate synthesis by 67% compared to experiments without DCNP incubation [4.8 vs 14.7 nmol/(10(6) cells.hr)] (P < 0.05). GSH and AA-GSH synthesis rates did not change compared to control experiments in which sulphation was not inhibited [1165 vs 1487 nmol/(10(6) cells.min), respectively] and [1.7 vs 1.7 nmol/(10(6) cells.hr), respectively]. This indicates that increased sulphur availability due to decreased PAPS synthesis is unable to raise the cysteine pool and stimulate the gamma-glutamyl cycle and GSH synthesis.
本研究的目的是在分离的大鼠肝细胞中,选择性抑制谷胱甘肽(GSH)生物合成或硫酸化后,检测肝毒性药物对乙酰氨基酚(AA)对GSH、活性硫酸盐(PAPS;3'-磷酸腺苷5'-磷酸硫酸)以及AA代谢产物AA-GSH和AA-硫酸盐合成速率的影响。通过丁硫氨酸亚砜胺(BSO)和2,6-二氯-4-硝基苯酚(DCNP)实现对这两条相互依赖的代谢途径的选择性抑制。基于对预标记的GSH和PAPS池中放射性(35S)的捕获,采用先前描述的方法同时测定GSH和PAPS的合成速率。用10 mM BSO预孵育30分钟使GSH减少38%(P < 0.05),PAPS减少27%(P < 0.05)。这种减少导致在低的、无毒的[5 - 19 nmol/(10⁶个细胞·分钟)](P < 0.05)和高的、有毒的[7 - 30 nmol/10⁶个细胞·分钟)](P < 0.05)AA浓度下PAPS合成增加。在这两种情况下,硫从GSH生物合成转向硫酸氧化和PAPS合成,从而维持PAPS池并保留硫酸化能力。这与以下发现一致,即无论AA浓度如何,AA硫酸化均不受BSO影响[分别为6 vs 5和20 vs 17 nmol/(10⁶个细胞·小时)]。尽管BSO预孵育后GSH合成减半,但AA的GSH结合能力仍得到很好的保留。与未用DCNP孵育的实验相比,用200 μM DCNP和5 mM AA孵育使PAPS合成从24降至10 nmol/(10⁶个细胞·分钟)(P < 0.02), 并使AA-硫酸盐合成减少67%[4.8 vs 14.7 nmol/(10⁶个细胞·小时)](P < 0.05)。与未抑制硫酸化的对照实验相比,GSH和AA-GSH合成速率没有变化[分别为1165 vs 1487 nmol/(10⁶个细胞·分钟)]和[1.7 vs 1.7 nmol/(10⁶个细胞·小时)]。这表明由于PAPS合成减少导致的硫可用性增加无法提高半胱氨酸池并刺激γ-谷氨酰循环和GSH合成。